Cancer HealthCast: NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
Inside the Navy’s Push for Resilient, AI-Enabled Command Centers
Officials outline how the Navy is modernizing Maritime Operations Centers with AI, modular tech and resilient cloud architectures.
5m read -
NASA Sees Industry Opportunity in Proposed Budget Cuts
During NASA's budget hearing, Administrator Jared Isaacman said commercial capabilities help close the gaps in funding.
3m read -
Coast Guard Launches RAS PEO to Unify Uncrewed Systems
New program office centralizes air, surface, underwater and space domains as the service moves from experimentation to institutionalized autonomy.
3m read -
Adversarial AI Threats Put Pressure on Federal Cyber Defenses
HP Federal keeps tabs on how threat actors exploit AI and what agencies must do to respond.
9m watch
